Comparer des méthodes

	GWAS bayésien	Étude d'association pangénomique (GWAS)
Domaine	Bio-informatique	Bio-informatique
Famille	Process / pipeline	Process / pipeline
Année d'origine	2007–2009 (formal statistical framework)	2005–2007
Auteur d'origine	Matthew Stephens, David J. Balding, Jon Wakefield (key formalizers ca. 2007–2009)	Klein et al. (age-related macular degeneration GWAS, 2005); landmark scale: Wellcome Trust Case Control Consortium (2007)
Type	Statistical genetic association analysis	Observational genomic association study
Source fondatrice	Stephens, M., & Balding, D. J. (2009). Bayesian statistical methods for genetic association studies. Nature Reviews Genetics, 10(10), 681–690.	Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447(7145), 661–678.
Alias	Bayesian GWAS, Bayesian genome-wide association analysis, Bayesian GWA study, BF-GWAS	GWAS, genome-wide association analysis, whole-genome association study, WGAS
Apparentées	5	6
Résumé	Bayesian GWAS applies Bayesian statistical inference to genome-wide association studies, replacing classical p-value thresholds with Bayes factors and posterior probabilities. This framework naturally incorporates prior knowledge about effect sizes and variant frequencies, quantifies evidence for association on a continuous scale, and supports principled fine-mapping of causal variants within associated loci. It is widely used in complex trait genetics, population genomics, and translational research where uncertainty quantification and multi-variant modeling matter.	A genome-wide association study (GWAS) systematically tests hundreds of thousands to millions of single-nucleotide polymorphisms (SNPs) across the human genome for statistical association with a trait or disease. By comparing allele frequencies between cases and controls — or by regressing SNP genotypes on a quantitative phenotype — GWAS identifies genomic loci that harbor common genetic variants contributing to complex traits. Since its large-scale debut in 2007, GWAS has catalogued thousands of robust disease–variant associations across virtually every common human condition.